Venus Concept Inc

Venus Concept Inc (VERO) Stock Analysis

$1.140

-0.039 (-3.39%)At close

Loading chart…
High
1.280
Open
1.160
VWAP
1.16
Vol
560.44K
Mkt Cap
5.11M
Low
1.065
Amount
651.04K
EV/EBITDA, TTM
0.00

Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.

Valuation Metrics

The current forward P/E ratio for Venus Concept Inc (VERO) is -0.13, compared to its 5-year average forward P/E of -1.08.

Forward P/E

Fair
5Y Average P/E
-1.08
Current P/E
-0.13
Overvalued
0.57
Undervalued
-2.73

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-12.11
Current EV/EBITDA
0.00
Overvalued
6.17
Undervalued
-30.39

Forward P/S

Fair
5Y Average P/S
0.24
Current P/S
0.04
Overvalued
0.52
Undervalued
-0.04

Alphio AI Price Scenarios for VERO

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%VERO

$2.19

Scenario price

B

Base

Base · 50%VERO

$2.12

Scenario price

B

Bear

Bear · 25%VERO

$1.83

Scenario price

Events Timeline

2026-05-13 (ET)

17:30:00

Venus Concept Appoints New Senior Leadership Team

2026-01-21 (ET)

07:40:00

Venus Concept Voluntarily Delists and Deregisters Common Stock

2025-11-13 (ET)

07:12:28

Venus Concept announces Q3 EPS of $12.14, compared to $13.10 in the previous year.

2025-11-10 (ET)

07:54:04

Venus Concept Secures 510(k) Approval for Venue NOVA

2025-06-20 (ET)

17:29:07

Venus Concept files to sell 900K shares of common stock for holders

News

VERO FAQ — answered by Alphio AI

Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started